Prof. Dr. med.; M.Sc. Michael Brändle
Chefarzt
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen · Dept. I
Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
Brändle M. Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie - Contra - eine kritische Beurteilung. Swiss Medical Forum 2010; 10:88-91.
04.02.2010Therapie des Diabetes mellitus Typ 2 mit bariatrischer Chirurgie
04.02.2010Swiss Medical Forum 2010; 10:88-91
Brändle Michael
Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
Schimke K, Greminger P, Brändle M. Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51.
01.11.2009Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration
01.11.2009Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2009; 117:649-51
Schimke Katrin-Elisabeth, Greminger Peter, Brändle Michael
Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Christ E, Maecke H, Martius F, Gloor B, Clerici T, Sahli R, Brändle M, Forrer F, Wild D, Reubi J. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. The Journal of clinical endocrinology and metabolism 2009; 94:4398-405.
01.11.2009Glucagon-like peptide-1 receptor imaging for localization of insulinomas
01.11.2009The Journal of clinical endocrinology and metabolism 2009; 94:4398-405
Christ Emanuel, Maecke Helmut, Martius Ferdinand, Gloor Beat, Clerici Thomas, Sahli Rahel, Brändle Michael, Forrer Flavio, Wild Damian, Reubi Jean Claude
[New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]
Lehmann R, Troendle A, Brändle M, Schweizerischen Gesellschaft für Endokrinologie und Diabetologie. [New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]. Therapeutische Umschau. Revue thérapeutique 2009; 66:695-706.
01.10.2009[New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes]
01.10.2009Therapeutische Umschau. Revue thérapeutique 2009; 66:695-706
Lehmann Roger, Troendle A, Brändle Michael, Schweizerischen Gesellschaft für Endokrinologie und Diabetologie
Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
Brändle M, Erny-Albrecht K, Goodall G, Spinas G, Streit P, Valentine W. Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland. International journal of clinical pharmacology and therapeutics 2009; 47:501-15.
01.08.2009Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland
01.08.2009International journal of clinical pharmacology and therapeutics 2009; 47:501-15
Brändle Michael, Erny-Albrecht K M, Goodall G, Spinas G A, Streit P, Valentine W J
Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism
Goede D, Wiesli P, Brändle M, Bestmann L, Bernays R, Zwimpfer C, Schmid C. Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:339-44.
13.06.2009Effects of thyroxine replacement on serum creatinine and cystatin C in patients with primary and central hypothyroidism
13.06.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:339-44
Goede Diane L, Wiesli Peter, Brändle Michael, Bestmann Lukas, Bernays René L, Zwimpfer Cornelia, Schmid Christoph
New onset alopecia and hirsutism in a postmenopausal women
Bühler-Christen A, Tischler V, Diener P, Brändle M. New onset alopecia and hirsutism in a postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009; 25:324-7.
01.05.2009New onset alopecia and hirsutism in a postmenopausal women
01.05.2009Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2009; 25:324-7
Bühler-Christen Annette, Tischler Verena, Diener Pierre-André, Brändle Michael
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
Brändle M, Goodall G, Erny-Albrecht K, Erdmann E, Valentine W. Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:173-84.
21.03.2009Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting
21.03.2009Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2009; 139:173-84
Brändle Michael, Goodall G, Erny-Albrecht K M, Erdmann E, Valentine W J
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
Marre M, Colagiuri S, Le Thi T, Zdravkovic M, Strand J, Kamaruddin N, Bebakar W, Brändle M, Shaw J, LEAD-1 SU study group. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic medicine : a journal of the British Diabetic Association 2009; 26:268-78.
01.03.2009Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
01.03.2009Diabetic medicine : a journal of the British Diabetic Association 2009; 26:268-78
Marre M, Colagiuri S, Le Thi T D, Zdravkovic M, Strand J, Kamaruddin N A, Bebakar W M W, Brändle Michael, Shaw J, LEAD-1 SU study group
Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus
Phillippe J, Weissenberger B, Stahl M, Ruiz J, Kuntschen F, Keller U, Diem P, Carrel J, Brändle M, Spinas G. Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus - Consensus Statement der Schweizerischen Gesellschaft für Endokrinologie. Swiss Medical Forum 2009; 9:50-55.
22.01.2009Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus
22.01.2009Swiss Medical Forum 2009; 9:50-55
Phillippe Jacques, Weissenberger Benno, Stahl Matthias, Ruiz Juan, Kuntschen François, Keller Ulrich, Diem Peter, Carrel Jacques, Brändle Michael, Spinas Giatgen A
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
Templeton A, Brändle M, Cerny T, Gillessen Sommer S. Remission of diabetes while on sunitinib treatment for renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5.
01.04.2008Remission of diabetes while on sunitinib treatment for renal cell carcinoma
01.04.2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:824-5
Templeton Arnoud, Brändle Michael, Cerny Thomas, Gillessen Sommer Silke
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
Strasser F, Cerny T, Von Moss R, Brändle M, Holst B, Kaufmann K, Tschöp M, Büche D, Thürlimann B, Maeder M, Lutz T, Demmer-Steingruber R. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. BJC 2008; 98:300-8.
29.01.2008Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
29.01.2008BJC 2008; 98:300-8
Strasser Florian, Cerny Thomas, Von Moss Roger, Brändle Michael, Holst B, Kaufmann K, Tschöp M, Büche Daniel, Thürlimann Beat, Maeder Micha, Lutz T A, Demmer-Steingruber Ruth
[19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)]
Lipowsky C, Schorl-Schweikardt B, Kehl O, Brändle M. [19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)]. Praxis 2008; 97:77-81.
23.01.2008[19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)]
23.01.2008Praxis 2008; 97:77-81
Lipowsky Christof, Schorl-Schweikardt B A, Kehl Oth, Brändle Michael
Cost analysis of diabetes and pregnancy
Brändle M. Cost analysis of diabetes and pregnancy. In: Textbook of Diabetes and Pregnancy. 2nd EditionLondon, England: Informa Health Care, 2008. ISBN 978 0 415 42620 6. S. 392-398.
01.01.2008Cost analysis of diabetes and pregnancy
01.01.2008Informa Health Care, ISBN 978 0 415 42620 6
Brändle Michael
Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%)
Preusser S, Diener P, l'Allemand-Jander D, Schmid S, Leippold T, Brändle M, Schmid H. Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%). Urology 2007; 70:1223.e7-9.
01.12.2007Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%)
01.12.2007Urology 2007; 70:1223.e7-9
Preusser Stefan, Diener Pierre-André, l'Allemand-Jander Dagmar, Schmid Sacha, Leippold Thomas, Brändle Michael, Schmid Hans-Peter
National survey on the management of primary hyperparathyroidism by Swiss endocrinologists
Clerici T, Warschkow R, Triponez F, Brändle M. National survey on the management of primary hyperparathyroidism by Swiss endocrinologists. Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2007; 392:611-5.
01.09.2007National survey on the management of primary hyperparathyroidism by Swiss endocrinologists
01.09.2007Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2007; 392:611-5
Clerici Thomas, Warschkow Rene, Triponez F, Brändle Michael
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
Valentine W, Massi-Benedetti M, Tan M, Yates J, Dormandy J, Williams R, Foos V, Brändle M, Palmer A, Bottomley J, PROactive Study Group. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Diabetic medicine : a journal of the British Diabetic Association 2007; 24:982-1002.
01.09.2007PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
01.09.2007Diabetic medicine : a journal of the British Diabetic Association 2007; 24:982-1002
Valentine W J, Massi-Benedetti M, Tan M H, Yates J, Dormandy J A, Williams R, Foos V, Brändle Michael, Palmer A J, Bottomley J M, PROactive Study Group
To autotransplant simultaneously or not -- can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia?
Müller-Stich B, Brändle M, Binet F, Warschkow R, Lange J, Clerici T. To autotransplant simultaneously or not -- can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia?. Surgery 2007; 142:47-56.
01.07.2007To autotransplant simultaneously or not -- can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia?
01.07.2007Surgery 2007; 142:47-56
Müller-Stich Beat P, Brändle Michael, Binet Françoise-Isabelle, Warschkow Rene, Lange Jochen, Clerici Thomas
Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland
Brändle M, Azoulay M, Greiner R. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland. International journal of clinical pharmacology and therapeutics 2007; 45:203-20.
01.04.2007Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland
01.04.2007International journal of clinical pharmacology and therapeutics 2007; 45:203-20
Brändle Michael, Azoulay M, Greiner R A
Current perspectives on coronary revascularization in the diabetic patient
Roffi M, Brändle M, Robbins M, Mukherjee D. Current perspectives on coronary revascularization in the diabetic patient. Indian heart journal 2007; 59:124-36.
07.03.2007Current perspectives on coronary revascularization in the diabetic patient
07.03.2007Indian heart journal 2007; 59:124-36
Roffi Marco, Brändle Michael, Robbins Mark A, Mukherjee Debabrata